Building towards a consensus for the use of tumour necrosis factor blocking agents

Ítems similars

• Updated consensus statement on tumour necrosis factor blocking agents for the treatment of rheumatoid arthritis and other rheumatic diseases (April 2001)
  per: FURST, D, et al.
  Publicat: (2001)
• Updated consensus statement on tumour necrosis factor blocking agents for the treatment of rheumatoid arthritis (May 2000)
  per: FURST, D, et al.
  Publicat: (2000)
• Updated consensus statement on biological agents, specifically tumour necrosis factor α (TNFα) blocking agents and interleukin-1 receptor antagonist (IL-1ra), for the treatment of rheumatic diseases, 2004
  per: Furst, D, et al.
  Publicat: (2004)
• Updated consensus statement on biological agents, specifically tumour necrosis factor α (TNFα) blocking agents and interleukin-1 receptor antagonist (IL-1ra), for the treatment of rheumatic diseases, 2005
  per: Furst, D, et al.
  Publicat: (2005)
• Consensus statement on the initiation and continuation of tumour necrosis factor blocking therapies in rheumatoid arthritis(*)
  per: Smolen, J., et al.
  Publicat: (2000)